eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
3/2022
vol. 39
 
Share:
Share:
more
 
 
abstract:
Review paper

Diagnostics of autoimmune blistering disorders: an experience of a single tertiary referral centre

Alicja Adaszewska
1
,
Katarzyna Woźniak
1
,
Agnieszka Kalińska-Bienias
1
,
Katarzyna Smolarczyk
2
,
Cezary Kowalewski
1

1.
Department of Dermatology and Immunodermatology, Medical University of Warsaw, Warsaw, Poland
2.
Department of Dermatology and Venereology, Medical University of Warsaw, Warsaw, Poland
Adv Dermatol Allergol 2022; XXXIX (3): 446-453
Online publish date: 2020/11/04
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Autoimmune blistering disorders (AIBD) include a heterogeneous group of diseases characterized by the presence of autoantibodies against the structural antigens of the skin and mucous membranes. The gold standard of AIBD diagnostics is the detection of in vivo bound IgG/IgA and/or complement component 3 in the direct immunofluorescence of a perilesional biopsy. Various immunological techniques such as indirect immunofluorescence of different tissue substrates including monkey oesophagus, salt split skin, recombinant proteins of epidermis and basement membrane zone as well as ELISA systems and immunoblotting are used to characterize target antigens. Proper and early diagnosis is crucial for both treatment and prognosis since some AIBD may be associated with a malignant neoplasm.
keywords:

immunofluorescence, autoimmune blistering disorders, pemphigus, pemphigoid, BIOCHIP, ELISA

Quick links
© 2022 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.